Sage Therapeutics, Inc (SAGE): Market Capitalization

Public company logo of Sage Therapeutics (SAGE)

This daily price chart for Sage Therapeutics, Inc. (SAGE) reflects the performance of a company developing CNS therapies. The business relies on external contractors for drug manufacturing while maintaining strict internal oversight. Its monopoly status in the treatment of postpartum depression provides significant pricing power, with a market capitalization of 0.55. However, sluggish sales growth and the threat of shutting down Alzheimer's projects are forcing management to preserve liquidity.

Sage Therapeutics - SAGE Market Value (period 07/04/2022 - 08/16/2025)

SAGE (Sage Therapeutics): analytical breakdowns and indicator data

Fundamental company analysis:SAGE (Sage Therapeutics, Inc)
Product sample of sagerx.com

Market capitalization is calculated as the product of the current share price and the total number of outstanding securities. This indicator determines the aggregate market weight of the business and its investment attractiveness. For Sage Therapeutics, Inc. (SAGE), an asset-light model reduces capital expenditures, shifting the focus toward scaling high-margin sales. The price action of the company's total outstanding shares reflects market confidence in the success of its neurological drugs. Analysis of this chart allows for a real-time assessment of the business value prior to the publication of quarterly reports.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|neumoratx.com (NMRA) - Market Value|Market Value Scilex Holding Company (SCLX)|TVGN (Tevogen Bio Holdings Inc.) - Market Capitalization|ACOG: Market Value|Market Capitalization CGTX|Market Capitalization Inhibikase Therapeutics Inc (IKT)|Cassava - Market Valuation|assertiotx.com (ASRT) - Market Value|COYA - Market Value|Market Value VTGN (VistaGen Therapeutics, Inc.)|OVID: Market Capitalization|Acumen Pharmaceuticals Inc. (ABOS) - Market Capitalization|Market Value CervoMed Inc.|ATHE: Market Value|Market Value Clene (CLNN)|PEPG: Market Valuation|Market Value Jupiter Neurosciences, Inc. JUNS|Market Capitalization Relmada Therapeutics Inc RLMD|ANVS - Market Value|GRCE - Market Capitalization|AIFF: Market Capitalization|KLTO - Market Capitalization|NRSN (NeuroSense Therapeutics, Ltd.) - Market Capitalization|Market Capitalization Reviva Pharmaceuticals Holdings|Market Capitalization MTVA|Market Capitalization NeurAxis Inc|Helius Medical Technologies - Market Valuation|Market Capitalization Passage Bio, Inc. PASG|NEUP: Market Valuation|Minerva Neurosciences, Inc. (NERV) - Market Valuation|ATHA (Athira Pharma) - Market Valuation|Market Capitalization ADXN|Market Value Alzamend Neuro, Inc.|Market Valuation cyclerion.com (CYCN)|Market Capitalization PTIX|Market Capitalization Pasithea (KTTA)|Market Value Cortigent CRGT|Market Capitalization Avenue Therapeutics Inc (ATXI)|BCLI - Market Value|CARA - Market Capitalization|CHRO: Market Capitalization|Eliem (ELYM) - Market Capitalization|Market Valuation ITCI|Market Value LBPH|Market Value marinuspharma.com (MRNS)|NKGN - Market Value|Market Value NeuroBo NRBO|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics